Pneumococcal conjugate second or third-dose vaccines (PCVc) in Greece
Greece: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 89.0% in 2025. ◆ Volatile
Latest (2025)
89.0%
Change on year
down 1.1%
World rank
72nd
of 194 countries
All-time high
96.0%
in 2014
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Greece, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Greece stood at 89.0%.
Compared with earlier readings it is down 1.1% on the previous year and down 7.3% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Greece peaked at 96.0% in 2014 and was at its lowest, 0.0%, in 2008.
Greece ranks 72nd of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Greece, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 32.0% | — |
| 2013 | 32.0% | +0.0% |
| 2014 | 96.0% | +200.0% |
| 2015 | 96.0% | +0.0% |
| 2016 | 96.0% | +0.0% |
| 2017 | 96.0% | +0.0% |
| 2018 | 96.0% | +0.0% |
| 2019 | 96.0% | +0.0% |
| 2020 | 96.0% | +0.0% |
| 2021 | 96.0% | +0.0% |
| 2022 | 93.0% | -3.1% |
| 2023 | 90.0% | -3.2% |
| 2024 | 90.0% | +0.0% |
| 2025 | 89.0% | -1.1% |
Greece compared with similar countries
- Greece's 89.0% is below the median for high income countries, which is 91.0%, 98% of the median. (63 countries reporting)
- Greece's 89.0% is above the median for Europe & Central Asia, which is 87.0%, 1.0× the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 64.0% | 0.0% | 96.0% | 10 |
| 2020s | 92.3% | 89.0% | 96.0% | 6 |
Countries ranked near Greece
More health data for Greece
- Un projection of annual infant deaths, annual growth rate -4 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0227 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,321 deaths per 1,000 people (2090)
- Number of infants who die before age 1 24 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.24 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0175 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.88 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Greece?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Greece was 89.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Greece?
- The highest recorded value was 96.0% in 2014.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Greece?
- The lowest recorded value was 0.0% in 2008.
- How does Greece rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Greece ranks 72nd out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Greece?
- Over the last ten years it is down 7.3%. The long-run trend across the full record is volatile.
- Where does this Greece data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).